Georgianna Maule-Ffinch 2015 Trust - 10 Apr 2023 Form 3 Insider Report for Better Therapeutics, Inc.

Role: 10%+ Owner
Signature: /s/ Mark Heinen, Attorney-in-Fact for Georgianna Maule-Ffinch 2015 Trust
Issuer symbol: BTTX on OTC
Transactions as of: 10 Apr 2023
Net transactions value: $0
Form type: 3
Filing time: 17 Apr 2023, 16:15:13 UTC
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	BTTX	Common Stock						3,636,364	10 Apr 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On April 6, 2023, the Issuer entered into a Securities Purchase Agreement with certain investors (the "PIPE Investors") in a private placement offering, pursuant to which the PIPE Investors agreed to purchase shares of Issuer common stock for $0.825 per share. As one of the PIPE Investors, the Reporting Person acquired 3,636,364 shares of Issuer common stock on April 10, 2023 for $0.825 per share.

Content

On April 6, 2023, the Issuer entered into a Securities Purchase Agreement with certain investors (the "PIPE Investors") in a private placement offering, pursuant to which the PIPE Investors agreed to purchase shares of Issuer common stock for $0.825 per share. As one of the PIPE Investors, the Reporting Person acquired 3,636,364 shares of Issuer common stock on April 10, 2023 for $0.825 per share.

Remarks:

Exhibit 24 - Power of Attorney